Gervais Debra A, Goldberg S Nahum, Brown Daniel B, Soulen Michael C, Millward Steven F, Rajan Dheeraj K
Department of Radiology, Division of Abdominal Imaging and Intervention, Massachusetts General Hospital, White 270, 55 Fruit St, Boston, MA 02114, USA.
J Vasc Interv Radiol. 2009 Jul;20(7 Suppl):S342-7. doi: 10.1016/j.jvir.2009.04.029.
Focal tumor ablation--whether applied percutanously, laparoscopically, or by means of open surgery--is an effective therapy for selected liver tumors. The choice of liver ablation as well as the choice between percutaneous and surgical approaches is dependent on tumor factors, patient factors, and other viable treatment options. Currently, the largest cumulative reported experience is with radiofrequency (RF) ablation of hepatocellular carcinoma and colorectal metastases. This document is a position statement of the Interventional Oncology Task Force and the Standards Division of the Society of Interventional Radiology regarding the use of percutaneous RF ablation for the treatment of liver tumors.
局部肿瘤消融——无论是经皮、腹腔镜还是通过开放手术进行——对于特定的肝脏肿瘤是一种有效的治疗方法。肝脏消融方式的选择以及经皮和手术方法之间的选择取决于肿瘤因素、患者因素和其他可行的治疗选择。目前,报告累积经验最多的是肝细胞癌和结直肠癌转移灶的射频(RF)消融。本文档是介入肿瘤学特别工作组和介入放射学会标准部关于使用经皮射频消融治疗肝脏肿瘤的立场声明。